BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21182473)

  • 1. Emerging role of antioxidants in the protection of uveitis complications.
    Yadav UC; Kalariya NM; Ramana KV
    Curr Med Chem; 2011; 18(6):931-42. PubMed ID: 21182473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel antioxidant approaches to the treatment of upper airway inflammation.
    Braskett M; Riedl MA
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):34-41. PubMed ID: 19935060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.
    Barry RJ; Tallouzi MO; Bucknall N; Mathers JM; Murray PI; Calvert MJ; Moore DJ; Denniston AK
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012577. PubMed ID: 30562409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.
    Aranda ML; Fleitas MFG; Dieguez H; Iaquinandi A; Sande PH; Dorfman D; Rosenstein RE
    Curr Neuropharmacol; 2017; 15(7):951-962. PubMed ID: 28088912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxidative stress in uveitis and its correction with superoxide dismutase antioxidative enzyme (experimental study)].
    Chesnokova NB; Neroev VV; Beznos OV; Beĭshenova GA; Nikol'skaia II; Kost OA; Binevskiĭ PV; Shekhter AB
    Vestn Oftalmol; 2014; 130(5):30-4. PubMed ID: 25711059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoic acid lessens Th1-mediated inflammation in lipopolysaccharide-induced uveitis reducing selectively Th1 lymphocytes-related cytokines release.
    Mérida S; Sancho-Tello M; Muriach M; Miranda M; Navea A; Bosch-Morell F
    Free Radic Res; 2013 Aug; 47(8):593-601. PubMed ID: 23678888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants.
    Bala A; Mondal C; Haldar PK; Khandelwal B
    Inflammopharmacology; 2017 Dec; 25(6):595-607. PubMed ID: 28929423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of lycopene on endotoxin-induced uveitis in rats.
    Göncü T; Oğuz E; Sezen H; Koçarslan S; Oğuz H; Akal A; Adıbelli FM; Çakmak S; Aksoy N
    Arq Bras Oftalmol; 2016; 79(6):357-362. PubMed ID: 28076559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Inflammation and Oxidative Stress as a Therapy for Ischemic Kidney Injury.
    Andrianova NV; Zorov DB; Plotnikov EY
    Biochemistry (Mosc); 2020 Dec; 85(12):1591-1602. PubMed ID: 33705297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
    Siti HN; Kamisah Y; Kamsiah J
    Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic arthritis-associated uveitis.
    Qian Y; Acharya NR
    Curr Opin Ophthalmol; 2010 Nov; 21(6):468-72. PubMed ID: 20729734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising drug therapy for non-infectious uveitis.
    Shahab MA; Mir TA; Zafar S
    Int Ophthalmol; 2019 Jul; 39(7):1633-1650. PubMed ID: 29961190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress mitigation by antioxidants - An overview on their chemistry and influences on health status.
    Pisoschi AM; Pop A; Iordache F; Stanca L; Predoi G; Serban AI
    Eur J Med Chem; 2021 Jan; 209():112891. PubMed ID: 33032084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
    Pashkow FJ; Watumull DG; Campbell CL
    Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terpene compounds in nature: a review of their potential antioxidant activity.
    González-Burgos E; Gómez-Serranillos MP
    Curr Med Chem; 2012; 19(31):5319-41. PubMed ID: 22963623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antioxidant formulation designed to treat male infertility associated with oxidative stress: promising preclinical evidence from animal models.
    Gharagozloo P; Gutiérrez-Adán A; Champroux A; Noblanc A; Kocer A; Calle A; Pérez-Cerezales S; Pericuesta E; Polhemus A; Moazamian A; Drevet JR; Aitken RJ
    Hum Reprod; 2016 Feb; 31(2):252-62. PubMed ID: 26732620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of small molecules/macromolecules in ocular inflammatory diseases.
    Liu B; Chan CC; Nussenblatt RB
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):113-20. PubMed ID: 22934741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA; Kasus-Jacobi A
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.